The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 22, Pages 5613
Publisher
MDPI AG
Online
2019-11-12
DOI
10.3390/ijms20225613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
- (2019) KLCA Korean Liver Cancer Association et al. Gut and Liver
- Micro RNA ‐223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes
- (2019) Yong He et al. HEPATOLOGY
- Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
- (2019) George N. Ioannou et al. JOURNAL OF HEPATOLOGY
- Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
- (2019) Stefania Grimaudo et al. Clinical Gastroenterology and Hepatology
- Non-alcoholic Steatohepatitis is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
- (2018) Zobair Younossi et al. Clinical Gastroenterology and Hepatology
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363
- (2018) Hai Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis
- (2018) Suraj A. Sharma et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry
- (2018) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Predictors of ultrasound failure to detect hepatocellular carcinoma
- (2018) Mariya L. Samoylova et al. LIVER TRANSPLANTATION
- Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
- (2018) Farzaneh Moshiri et al. Oncotarget
- The emergence of long non-coding RNAs in hepatocellular carcinoma: an update
- (2018) Li Peng et al. Journal of Cancer
- Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
- (2018) Jonathan G. Stine et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients with Cirrhosis: A Randomized Clinical Trial
- (2018) Amit G. Singal et al. HEPATOLOGY
- Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma
- (2018) Li Peng et al. CANCER RESEARCH
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
- (2018) Donghee Kim et al. GASTROENTEROLOGY
- miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
- (2018) Paola Dongiovanni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
- (2018) Zhenqiu Liu et al. JOURNAL OF HEPATOLOGY
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
- (2017) David Goldberg et al. GASTROENTEROLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue
- (2017) Changqing Zhao et al. LIVER INTERNATIONAL
- Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
- (2017) Shujuan Ma et al. MEDICINE
- Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI
- (2017) Kun-Fang Yao et al. Oncotarget
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
- (2017) Benedetta Donati et al. Scientific Reports
- Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
- (2016) O. Simmons et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
- (2016) Danielle K. DePeralta et al. CANCER
- From obesity to cancer: a review on proposed mechanisms
- (2016) Zoya Tahergorabi et al. CELL BIOCHEMISTRY AND FUNCTION
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis
- (2016) Edmondo Falleti et al. DIGESTIVE AND LIVER DISEASE
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
- (2016) Lei Li et al. HEPATOLOGY
- Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- (2016) Tracey G. Simon et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
- (2016) Fabio Piscaglia et al. HEPATOLOGY
- Emerging role of exosomes in liver physiology and pathology
- (2016) Shuangpeng Cai et al. HEPATOLOGY RESEARCH
- Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice
- (2016) Thatiany de Souza Marinho et al. HEPATOLOGY RESEARCH
- A micro-RNA expression signature for human NAFLD progression
- (2016) Yan Guo et al. JOURNAL OF GASTROENTEROLOGY
- The evolutionary scenario of hepatocellular carcinoma in Italy: an update
- (2016) Laura Bucci et al. LIVER INTERNATIONAL
- Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
- (2016) Takaaki Higashi et al. MEDICAL ONCOLOGY
- LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway
- (2016) X Wang et al. Cell Death & Disease
- Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
- (2016) Yao-Yao Zhou et al. Oncotarget
- LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration
- (2016) Dongmei Xiong et al. Oncotarget
- Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
- (2015) Lee-Won Chong et al. BMC GASTROENTEROLOGY
- Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population
- (2015) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA
- (2015) Alice Conigliaro et al. Molecular Cancer
- A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
- (2015) Stephan Buch et al. NATURE GENETICS
- Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma
- (2015) T Li et al. ONCOGENE
- miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan
- (2015) Tünde Halász WORLD JOURNAL OF GASTROENTEROLOGY
- Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization
- (2015) Elias Björnson et al. Cell Reports
- The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
- (2014) Amit G Singal et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Intake of Vegetables, But Not Fruit, Reduces Risk for Hepatocellular Carcinoma: A Meta-analysis
- (2014) Yang Yang et al. GASTROENTEROLOGY
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- Epigenetics in liver disease
- (2014) Derek A. Mann HEPATOLOGY
- Circulating RNA Molecules as Biomarkers in Liver Disease
- (2014) Liviu Enache et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
- (2014) Y.-L. Liu et al. JOURNAL OF HEPATOLOGY
- Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults
- (2014) Krishnan Bhaskaran et al. LANCET
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
- (2014) Salvatore Petta et al. PLoS One
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- MicroRNAs in Nonalcoholic Fatty Liver Disease: Novel Biomarkers and Prognostic Tools during the Transition from Steatosis to Hepatocarcinoma
- (2014) Manuele Gori et al. Biomed Research International
- Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma
- (2013) L. Zheng et al. CLINICAL CANCER RESEARCH
- Association between thePNPLA3(rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data
- (2013) Eric Trépo et al. HEPATOLOGY
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects
- (2013) Motoyuki Otsuka et al. JOURNAL OF GASTROENTEROLOGY
- Mediterranean diet and hepatocellular carcinoma
- (2013) Federica Turati et al. JOURNAL OF HEPATOLOGY
- Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
- (2013) Jessica Dyson et al. JOURNAL OF HEPATOLOGY
- PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma
- (2013) Luca Valenti et al. PLoS One
- Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
- (2013) Wei Wang et al. PLoS One
- Obesity and cancer risk: evidence, mechanisms, and recommendations
- (2012) Ivana Vucenik et al. Annals of the New York Academy of Sciences
- Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2012) A. G. Singal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice
- (2012) Wenfang Tian et al. HEPATOLOGY
- Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
- (2012) Y. Lee et al. HUMAN MOLECULAR GENETICS
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
- (2012) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases
- (2012) Chi-Pang Wen et al. JNCI-Journal of the National Cancer Institute
- Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression
- (2012) JANINE KAH et al. ONCOLOGY REPORTS
- Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
- (2011) Yusuke Kawamura et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
- (2011) Z. Cao et al. CANCER RESEARCH
- Family history of liver cancer and hepatocellular carcinoma
- (2011) Federica Turati et al. HEPATOLOGY
- Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
- (2011) Chenggang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
- (2011) Silvia Cermelli et al. PLoS One
- Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
- (2011) Elizabeth K. Speliotes et al. PLoS Genetics
- Inhibition of Autophagy Enhances Anticancer Effects of Atorvastatin in Digestive Malignancies
- (2010) P.-M. Yang et al. CANCER RESEARCH
- I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Obesity and Cancer Risk: Recent Review and Evidence
- (2010) Karen Basen-Engquist et al. Current Oncology Reports
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started